Murae Organisor Ltd
MURAEMurae Organisor Ltd
MURAE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -92.95 | 1.75 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs etc
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 18.63 | 23.69 | 35.85 | 50.75 | 57.38 | 50.01 | 28.74 | 16.36 | 4.06 | 1.46 | ||||||||||
Raw Materials | 19.04 | 24.94 | 34.93 | 48.87 | 52.82 | 48.34 | 21.83 | 13.11 | 2.14 | 2.55 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.01 | 0.02 | 0.02 | 0.04 | 0.01 | 0.02 | 0.05 | 0.01 | |||||||||||
| Employee Cost | 0.40 | 0.30 | 0.10 | 0.19 | 0.30 | 0.29 | 0.04 | 0.08 | 0.05 | |||||||||||
| Selling & Administrative Expenses | 0.66 | 0.49 | 0.52 | 0.90 | 2.88 | 2.25 | 0.34 | 0.76 | 0.52 | |||||||||||
| Operating & Other expenses | -2.04 | -2.83 | -1.70 | -2.58 | -2.17 | -2.05 | 3.23 | -0.83 | 0.95 | |||||||||||
EBITDA | 0.57 | 0.78 | 1.98 | 3.35 | 3.51 | 1.17 | 3.28 | 3.19 | 0.39 | -1.09 | ||||||||||
| Depreciation/Amortization | 0.02 | 0.02 | 0.02 | 0.04 | 0.10 | 0.12 | 0.12 | 0.10 | 0.06 | 0.06 | ||||||||||
| PBIT | 0.55 | 0.76 | 1.96 | 3.31 | 3.41 | 1.05 | 3.16 | 3.09 | 0.33 | -1.15 | ||||||||||
| Interest & Other Items | 0.39 | 0.52 | 0.72 | 1.04 | 0.97 | 0.93 | 0.08 | 0.29 | 0.26 | 0.01 | ||||||||||
| PBT | 0.16 | 0.24 | 1.24 | 2.27 | 2.44 | 0.12 | 3.08 | 2.80 | 0.07 | -1.16 | ||||||||||
| Taxes & Other Items | 0.07 | 0.08 | 0.33 | 0.62 | 0.63 | 0.03 | 0.86 | 0.81 | 0.02 | -0.11 | ||||||||||
| Net Income | 0.09 | 0.16 | 0.91 | 1.65 | 1.81 | 0.09 | 2.22 | 1.99 | 0.05 | -1.05 | ||||||||||
| EPS | 0.01 | 0.01 | 0.03 | 0.03 | 0.06 | 0.01 | 0.30 | 0.27 | 0.00 | -0.04 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Murae Organisor Ltd | 1,951.91 | 1.75 | — |
| Sun Pharmaceutical Industries Ltd | 45.34 | 6.47 | 0.75% |
| Cipla Ltd | 31.21 | 4.80 | 0.82% |
| Torrent Pharmaceuticals Ltd | 65.38 | 15.80 | 0.88% |
Price Comparison
Compare MURAE with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 38.61%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
May 2024
Jun 2024
Aug 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
MURAE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeMurae Organisor will hold a meeting of the Board of Directors of the Company on 15 October 2024.Powered by Capital Market - Live
Murae Organisor announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net Loss of Murae Organisor reported to Rs 0.24 crore in the quarter ended June 2024 as against net loss of Rs 0.28 crore during the previous quarter ended June 2023. Sales declined 86.55% to Rs 0.23 crore in the quarter ended June 2024 as against Rs 1.71 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.231.71 -87 OPM %-104.35-38.60 - PBDT-0.24-0.26 8 PBT-0.24-0.28 14 NP-0.24-0.28 14 Powered by Capital Market - Live
Murae Organisor has revised the meeting of the Board of Directors which was scheduled to be held on 12 August 2024. The meeting will now be held on 13 August 2024.Powered by Capital Market - Live
Murae Organisor will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
EID Parry board to consider dividend payment; Deep Industries shares will turn ex-split today
Gyscoal Alloys Ltd leads gainers in ‘B’ group
Earum Pharmaceuticals standalone net profit declines 99.26% in the September 2022 quarter
Earum Pharmaceuticals Ltd leads losers in ‘B’ group
Salasar Techno Engineering Ltd leads losers in ‘B’ group
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -39.66%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.02% to 0%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -50.31%, vs industry avg of 15.28%